World Bank defends efforts to curb malaria
The World Bank has been forced to rebut a series of stinging criticisms from public-health commentators. They have accused it of failing to fulfil its promise to provide funds and leadership for Africa's fight against malaria.
Last year, the World Bank made a fresh pledge to implement global antimalaria schemes worth up to US$1 billion over the next five years. This week's accusations mark the latest chapter in an acrimonious battle between the bank and a group of advocates who think it should hand the pledged funds over to agencies that, they argue, have greater public-health expertise.
The bank pledged in 2000 to make between $US300 million and $500 million available to African governments for antimalaria treatments and infrastructure. But the bank's critics point out that by 2005, no more than $150 million had been provided.
"In 2000, they made the largest ever promise to spend money on malaria in Africa, " says Amir Attaran, a law professor at the University of Ottawa, Canada, and lead author of a commentary that sets out the criticisms in this week's issue of The Lancet (A. Attaran et al. Lancet doi:10.1016/S0140-6736(06) 68545-0; 2006) . "It's now 2006, and they have broken that promise. " The commentary is co-authored by 12 epidemiology and public-health experts, from Africa, Europe and North America.
Bank officials admit that their initial drive was unsuccessful, partly because they did not receive as many applications from African governments as they expected. But they point out that the 2005 pledge, which aims to help the global Roll Back Malaria initiative hit its 2010 target of halving malaria cases, is already making progress. "These criticisms are a year out of date, " Suprotik Basu, a member of the bank's malaria team, told Nature. He says that, since the effort was relaunched last year, projects worth a total of $190 million have been approved in Eritrea, Niger, Zambia and the Democratic Republic of Congo, and that the total will stand at $400 million by July next year. The bank will provide roughly half of the money itself. It will broker deals with other banks and with nongovernment organizations such as the Seattlebased Bill and Melinda Gates Foundation to raise the remainder of the cash. But Attaran complains that the bank, which has an annual tax-funded budget of $20 billion, initially promised to raise all the funds by itself.
Charges levelled
More seriously, Attaran and his colleagues accuse the bank of massaging figures from previous malaria projects in Brazil and India to make them seem more successful. They also charge it with endorsing treatment options in India that will leave millions exposed to resistant forms of the disease.
Basu describes the allegations as "flat wrong". Data used to compile the bank's figures, given to Attaran upon request, came from peerreviewed studies, and were neither collected nor doctored by the bank. And Basu insists that the bank is working closely with the World Health Organization (WHO) to ensure that the treatments it funds are recommended ones.
Whereas most malaria in Africa is spread by the Plasmodium falciparum parasite and ideally treated using drugs called artemisinins, around half of India's cases are caused by P. vivax, and can be treated using the much Last hope for river dolphins 
